nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—BCHE—Cisplatin—bone cancer	0.459	1	CbGbCtD
Procaine—Meningism—Methotrexate—bone cancer	0.0328	0.0611	CcSEcCtD
Procaine—Arachnoiditis—Methotrexate—bone cancer	0.0312	0.058	CcSEcCtD
Procaine—Nephropathy—Methotrexate—bone cancer	0.012	0.0222	CcSEcCtD
Procaine—Body temperature increased—Carboplatin—bone cancer	0.00997	0.0186	CcSEcCtD
Procaine—Neuropathy—Cisplatin—bone cancer	0.00974	0.0181	CcSEcCtD
Procaine—Eruption—Methotrexate—bone cancer	0.00925	0.0172	CcSEcCtD
Procaine—Eruption—Epirubicin—bone cancer	0.00866	0.0161	CcSEcCtD
Procaine—Haemolytic anaemia—Cisplatin—bone cancer	0.00834	0.0155	CcSEcCtD
Procaine—Paralysis—Methotrexate—bone cancer	0.00819	0.0152	CcSEcCtD
Procaine—Eruption—Doxorubicin—bone cancer	0.00801	0.0149	CcSEcCtD
Procaine—Anaphylactoid reaction—Cisplatin—bone cancer	0.00778	0.0145	CcSEcCtD
Procaine—Paralysis—Epirubicin—bone cancer	0.00766	0.0143	CcSEcCtD
Procaine—Ventricular arrhythmia—Epirubicin—bone cancer	0.00719	0.0134	CcSEcCtD
Procaine—Paralysis—Doxorubicin—bone cancer	0.00709	0.0132	CcSEcCtD
Procaine—Apnoea—Methotrexate—bone cancer	0.00671	0.0125	CcSEcCtD
Procaine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00666	0.0124	CcSEcCtD
Procaine—Sweating increased—Cisplatin—bone cancer	0.00634	0.0118	CcSEcCtD
Procaine—Vasodilation—Epirubicin—bone cancer	0.00606	0.0113	CcSEcCtD
Procaine—Vasodilation procedure—Epirubicin—bone cancer	0.00606	0.0113	CcSEcCtD
Procaine—Neuropathy peripheral—Cisplatin—bone cancer	0.00569	0.0106	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—bone cancer	0.00561	0.0104	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—bone cancer	0.00561	0.0104	CcSEcCtD
Procaine—Atrioventricular block—Epirubicin—bone cancer	0.00549	0.0102	CcSEcCtD
Procaine—Bradycardia—Cisplatin—bone cancer	0.0053	0.00987	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—bone cancer	0.00508	0.00946	CcSEcCtD
Procaine—Neuropathy—Epirubicin—bone cancer	0.005	0.00931	CcSEcCtD
Procaine—Tinnitus—Cisplatin—bone cancer	0.00486	0.00904	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—bone cancer	0.00463	0.00861	CcSEcCtD
Procaine—Erythema—Cisplatin—bone cancer	0.00453	0.00844	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—bone cancer	0.00438	0.00815	CcSEcCtD
Procaine—Vision blurred—Cisplatin—bone cancer	0.00427	0.00795	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—bone cancer	0.00427	0.00795	CcSEcCtD
Procaine—Tremor—Cisplatin—bone cancer	0.00425	0.00791	CcSEcCtD
Procaine—Dermatitis exfoliative—Epirubicin—bone cancer	0.0041	0.00763	CcSEcCtD
Procaine—Leukopenia—Cisplatin—bone cancer	0.00406	0.00755	CcSEcCtD
Procaine—Anaphylactoid reaction—Epirubicin—bone cancer	0.00399	0.00744	CcSEcCtD
Procaine—Convulsion—Cisplatin—bone cancer	0.00393	0.00731	CcSEcCtD
Procaine—Anxiety—Cisplatin—bone cancer	0.00385	0.00716	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00379	0.00706	CcSEcCtD
Procaine—Anaphylactic shock—Cisplatin—bone cancer	0.0037	0.00689	CcSEcCtD
Procaine—Oedema—Cisplatin—bone cancer	0.0037	0.00689	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.0037	0.00688	CcSEcCtD
Procaine—Cardiac arrest—Epirubicin—bone cancer	0.00368	0.00684	CcSEcCtD
Procaine—Thrombocytopenia—Cisplatin—bone cancer	0.00362	0.00674	CcSEcCtD
Procaine—Tachycardia—Cisplatin—bone cancer	0.00361	0.00672	CcSEcCtD
Procaine—Hyperhidrosis—Cisplatin—bone cancer	0.00358	0.00666	CcSEcCtD
Procaine—Eosinophilia—Methotrexate—bone cancer	0.00353	0.00658	CcSEcCtD
Procaine—Hypotension—Cisplatin—bone cancer	0.00346	0.00644	CcSEcCtD
Procaine—Cardiac arrest—Doxorubicin—bone cancer	0.0034	0.00633	CcSEcCtD
Procaine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00337	0.00628	CcSEcCtD
Procaine—Eosinophilia—Epirubicin—bone cancer	0.00331	0.00616	CcSEcCtD
Procaine—Drowsiness—Methotrexate—bone cancer	0.00318	0.00593	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—bone cancer	0.00306	0.0057	CcSEcCtD
Procaine—Drowsiness—Epirubicin—bone cancer	0.00298	0.00555	CcSEcCtD
Procaine—Body temperature increased—Cisplatin—bone cancer	0.00292	0.00544	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—bone cancer	0.00292	0.00544	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—bone cancer	0.00276	0.00513	CcSEcCtD
Procaine—Hypersensitivity—Cisplatin—bone cancer	0.00273	0.00507	CcSEcCtD
Procaine—Bradycardia—Epirubicin—bone cancer	0.00272	0.00507	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—bone cancer	0.0027	0.00503	CcSEcCtD
Procaine—Tinnitus—Methotrexate—bone cancer	0.00266	0.00496	CcSEcCtD
Procaine—Chills—Methotrexate—bone cancer	0.00256	0.00477	CcSEcCtD
Procaine—Diarrhoea—Cisplatin—bone cancer	0.00253	0.00471	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—bone cancer	0.00252	0.00469	CcSEcCtD
Procaine—Tinnitus—Epirubicin—bone cancer	0.00249	0.00464	CcSEcCtD
Procaine—Erythema—Methotrexate—bone cancer	0.00249	0.00463	CcSEcCtD
Procaine—Chills—Epirubicin—bone cancer	0.0024	0.00447	CcSEcCtD
Procaine—Vomiting—Cisplatin—bone cancer	0.00235	0.00438	CcSEcCtD
Procaine—Vision blurred—Methotrexate—bone cancer	0.00234	0.00436	CcSEcCtD
Procaine—Rash—Cisplatin—bone cancer	0.00233	0.00434	CcSEcCtD
Procaine—Dermatitis—Cisplatin—bone cancer	0.00233	0.00434	CcSEcCtD
Procaine—Erythema—Epirubicin—bone cancer	0.00233	0.00433	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—bone cancer	0.00231	0.00429	CcSEcCtD
Procaine—Tension—Epirubicin—bone cancer	0.00228	0.00425	CcSEcCtD
Procaine—Nervousness—Epirubicin—bone cancer	0.00226	0.00421	CcSEcCtD
Procaine—Leukopenia—Methotrexate—bone cancer	0.00223	0.00415	CcSEcCtD
Procaine—Chills—Doxorubicin—bone cancer	0.00222	0.00413	CcSEcCtD
Procaine—Nausea—Cisplatin—bone cancer	0.0022	0.00409	CcSEcCtD
Procaine—Vision blurred—Epirubicin—bone cancer	0.00219	0.00408	CcSEcCtD
Procaine—Clomifene—CYP3A4—bone cancer	0.00217	0.529	CrCbGaD
Procaine—Convulsion—Methotrexate—bone cancer	0.00216	0.00401	CcSEcCtD
Procaine—Erythema—Doxorubicin—bone cancer	0.00215	0.00401	CcSEcCtD
Procaine—Agitation—Epirubicin—bone cancer	0.00214	0.00398	CcSEcCtD
Procaine—Arthralgia—Methotrexate—bone cancer	0.00212	0.00394	CcSEcCtD
Procaine—Tension—Doxorubicin—bone cancer	0.00211	0.00394	CcSEcCtD
Procaine—Nervousness—Doxorubicin—bone cancer	0.00209	0.00389	CcSEcCtD
Procaine—Syncope—Epirubicin—bone cancer	0.00209	0.00389	CcSEcCtD
Procaine—Leukopenia—Epirubicin—bone cancer	0.00208	0.00388	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—bone cancer	0.00205	0.00381	CcSEcCtD
Procaine—Anaphylactic shock—Methotrexate—bone cancer	0.00203	0.00378	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—bone cancer	0.00203	0.00378	CcSEcCtD
Procaine—Convulsion—Epirubicin—bone cancer	0.00202	0.00375	CcSEcCtD
Procaine—Hypertension—Epirubicin—bone cancer	0.00201	0.00374	CcSEcCtD
Procaine—Thrombocytopenia—Methotrexate—bone cancer	0.00199	0.0037	CcSEcCtD
Procaine—Arthralgia—Epirubicin—bone cancer	0.00198	0.00369	CcSEcCtD
Procaine—Agitation—Doxorubicin—bone cancer	0.00198	0.00369	CcSEcCtD
Procaine—Anxiety—Epirubicin—bone cancer	0.00198	0.00368	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—bone cancer	0.00196	0.00365	CcSEcCtD
Procaine—Syncope—Doxorubicin—bone cancer	0.00193	0.0036	CcSEcCtD
Procaine—Probenecid—CYP3A4—bone cancer	0.00193	0.471	CrCbGaD
Procaine—Leukopenia—Doxorubicin—bone cancer	0.00193	0.00359	CcSEcCtD
Procaine—Anaphylactic shock—Epirubicin—bone cancer	0.0019	0.00354	CcSEcCtD
Procaine—Oedema—Epirubicin—bone cancer	0.0019	0.00354	CcSEcCtD
Procaine—Hypotension—Methotrexate—bone cancer	0.0019	0.00353	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—bone cancer	0.00189	0.00352	CcSEcCtD
Procaine—Shock—Epirubicin—bone cancer	0.00187	0.00348	CcSEcCtD
Procaine—Convulsion—Doxorubicin—bone cancer	0.00187	0.00347	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—bone cancer	0.00186	0.00346	CcSEcCtD
Procaine—Hypertension—Doxorubicin—bone cancer	0.00186	0.00346	CcSEcCtD
Procaine—Tachycardia—Epirubicin—bone cancer	0.00185	0.00345	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00185	0.00344	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—bone cancer	0.00184	0.00342	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—bone cancer	0.00183	0.00341	CcSEcCtD
Procaine—Anxiety—Doxorubicin—bone cancer	0.00183	0.0034	CcSEcCtD
Procaine—Somnolence—Methotrexate—bone cancer	0.0018	0.00336	CcSEcCtD
Procaine—Hypotension—Epirubicin—bone cancer	0.00178	0.00331	CcSEcCtD
Procaine—Oedema—Doxorubicin—bone cancer	0.00176	0.00327	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—bone cancer	0.00176	0.00327	CcSEcCtD
Procaine—Fatigue—Methotrexate—bone cancer	0.00175	0.00326	CcSEcCtD
Procaine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00173	0.00322	CcSEcCtD
Procaine—Shock—Doxorubicin—bone cancer	0.00173	0.00322	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—bone cancer	0.00172	0.0032	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—bone cancer	0.00172	0.00319	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—bone cancer	0.0017	0.00316	CcSEcCtD
Procaine—Somnolence—Epirubicin—bone cancer	0.00169	0.00314	CcSEcCtD
Procaine—Hypotension—Doxorubicin—bone cancer	0.00164	0.00306	CcSEcCtD
Procaine—Fatigue—Epirubicin—bone cancer	0.00164	0.00305	CcSEcCtD
Procaine—Urticaria—Methotrexate—bone cancer	0.00161	0.003	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—bone cancer	0.0016	0.00299	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0016	0.00298	CcSEcCtD
Procaine—Somnolence—Doxorubicin—bone cancer	0.00156	0.00291	CcSEcCtD
Procaine—Fatigue—Doxorubicin—bone cancer	0.00152	0.00282	CcSEcCtD
Procaine—Urticaria—Epirubicin—bone cancer	0.00151	0.00281	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—bone cancer	0.0015	0.0028	CcSEcCtD
Procaine—Hypersensitivity—Methotrexate—bone cancer	0.0015	0.00278	CcSEcCtD
Procaine—Pruritus—Methotrexate—bone cancer	0.00144	0.00267	CcSEcCtD
Procaine—Hypersensitivity—Epirubicin—bone cancer	0.0014	0.00261	CcSEcCtD
Procaine—Urticaria—Doxorubicin—bone cancer	0.0014	0.0026	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—bone cancer	0.00139	0.00259	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—bone cancer	0.00139	0.00259	CcSEcCtD
Procaine—Pruritus—Epirubicin—bone cancer	0.00134	0.0025	CcSEcCtD
Procaine—Dizziness—Methotrexate—bone cancer	0.00134	0.0025	CcSEcCtD
Procaine—Diarrhoea—Epirubicin—bone cancer	0.0013	0.00242	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—bone cancer	0.0013	0.00241	CcSEcCtD
Procaine—Vomiting—Methotrexate—bone cancer	0.00129	0.0024	CcSEcCtD
Procaine—Rash—Methotrexate—bone cancer	0.00128	0.00238	CcSEcCtD
Procaine—Dermatitis—Methotrexate—bone cancer	0.00128	0.00238	CcSEcCtD
Procaine—Dizziness—Epirubicin—bone cancer	0.00126	0.00234	CcSEcCtD
Procaine—Pruritus—Doxorubicin—bone cancer	0.00124	0.00232	CcSEcCtD
Procaine—Vomiting—Epirubicin—bone cancer	0.00121	0.00225	CcSEcCtD
Procaine—Nausea—Methotrexate—bone cancer	0.00121	0.00224	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—bone cancer	0.0012	0.00224	CcSEcCtD
Procaine—Rash—Epirubicin—bone cancer	0.0012	0.00223	CcSEcCtD
Procaine—Dermatitis—Epirubicin—bone cancer	0.0012	0.00223	CcSEcCtD
Procaine—Dizziness—Doxorubicin—bone cancer	0.00116	0.00216	CcSEcCtD
Procaine—Nausea—Epirubicin—bone cancer	0.00113	0.0021	CcSEcCtD
Procaine—Vomiting—Doxorubicin—bone cancer	0.00112	0.00208	CcSEcCtD
Procaine—Rash—Doxorubicin—bone cancer	0.00111	0.00206	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—bone cancer	0.00111	0.00206	CcSEcCtD
Procaine—Nausea—Doxorubicin—bone cancer	0.00104	0.00194	CcSEcCtD
